Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Left Ventricular Systolic

Dongfeng Zhang1, Shuzheng Lyu2, Xiantao Song2

  • 1Department of Cardiology, Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Angiology
|April 13, 2016
PubMed

Insights

For patients with coronary artery disease and left ventricular systolic dysfunction, coronary artery bypass grafting (CABG) shows long-term benefits over percutaneous coronary intervention (PCI). CABG significantly reduces long-term death, myocardial infarction, and repeat revascularization.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Optimal coronary revascularization strategy for patients with coronary artery disease (CAD) and left ventricular (LV) systolic dysfunction remains debated.
  • Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are primary revascularization methods.

Purpose of the Study:

  • To compare the efficacy and safety of CABG versus PCI in patients with CAD and LV systolic dysfunction.
  • To evaluate long-term outcomes including mortality, myocardial infarction, and need for repeat revascularization.

Main Methods:

  • A systematic meta-analysis was conducted.
  • Searched PubMed, EMBASE, and Cochrane Controlled Trials Register for relevant studies.
  • Included 4 prospective and 5 retrospective studies involving 6082 patients published before March 2015.

Main Results:

  • CABG was associated with significantly lower long-term death (OR: 0.82, P = .01) compared to PCI.
  • CABG demonstrated significantly lower rates of myocardial infarction (OR: 0.58, P = .03) and repeat revascularization (OR: 0.17, P < .001).
  • Short-term mortality rates were comparable between CABG and PCI (OR: 2.09, P = .13).

Conclusions:

  • Coronary artery bypass grafting offers significant long-term survival and clinical benefits over percutaneous coronary intervention in patients with CAD and LV systolic dysfunction.
  • CABG is a preferred revascularization strategy for this patient population, considering long-term outcomes.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
395
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
738
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
419